Constitutive production of a factor supporting B lymphocyte differentiation by a T cell hybridoma.
To investigate the role of soluble T cell products during B cell differentiation more fully, we have produced T cell hybridomas by the fusion of normal helper T cells with the T cell lymphoma BW5147. In this report we describe the production of one such hybrid, 14G3, the subclone 14G3.1F2, and the functional activity of the constitutive product. The hybrid supernatant acts exclusively in antigen-nonspecific, but antigen-dependent, promotion of B cell differentiation. It is optimally effective in the presence of small amounts of EL4 supernatant. It does not itself contain any detectable IL 2 or BCGF or interferon activity, however. 14G3.1F2 activity is probably an important component of the conventional TRF preparations produced by mixed lymphocyte populations, and will be useful in further dissection of the contributions of different soluble T cell products to B cell differentiation.
D000818:Animals; D000921:Antibody-Producing Cells / Q000276:immunology; D005260:Female; D006133:Growth Substances / Q000096:biosynthesis*; D006462:Hemolytic Plaque Technique; D006736:Horses; D006825:Hybridomas / Q000378:metabolism*; D007376:Interleukin-2 / Q000032:analysis; D015847:Interleukin-4; D015848:Interleukin-5; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D012756:Sheep; D013601:T-Lymphocytes / Q000378:metabolism*
D006133:Growth Substances; D007376:Interleukin-2; D015848:Interleukin-5; D008222:Lymphokines; D015847:Interleukin-4